Asthma categories?,”- Intermittent: daytime symptoms <2x/week, nighttime awakenings <2 month, beta-agonist <2x/week, normal baseline FEV1 and FEV1/FVC, and no limitations on daily activities. Treat with short acting beta-2 agonist (albuterol)-Mild persistent: symptoms > 2 days/week but not daily, nighttime awakening 3-4x/month, minor limitation on activities, and normal PFTs.Treat with PRN albuterol inhaler plus inhaled corticosteroids. -Moderate persistent: symptoms daily, weekly nighttime awakenings, moderate limitation on activities, and FEV1 60-80% of predicted. Treat with PRN albuterol inhaler, low-dose inhaled corticosteroids, and long-acting inhaled beta-2 agonist inhaler. -Severe persistent: symptoms throughout the day, frequent nighttime awakenings, extremely limited activity, and FEV1 <60% predicted.Treat with PRN albuterol inhaler, long-acting beta-2 agonist inhaler

Asthma categories?,”- Intermittent: daytime symptoms <2x/week, nighttime awakenings <2 month, beta-agonist <2x/week, normal baseline FEV1 and FEV1/FVC, and no limitations on daily activities. Treat with short acting beta-2 agonist (albuterol)-Mild persistent: symptoms > 2 days/week but not daily, nighttime awakening 3-4x/month, minor limitation on activities, and normal PFTs.Treat with PRN albuterol inhaler plus inhaled corticosteroids. -Moderate persistent: symptoms daily, weekly nighttime awakenings, moderate limitation on activities, and FEV1 60-80% of predicted. Treat with PRN albuterol inhaler, low-dose inhaled corticosteroids, and long-acting inhaled beta-2 agonist inhaler. -Severe persistent: symptoms throughout the day, frequent nighttime awakenings, extremely limited activity, and FEV1 <60% predicted.Treat with PRN albuterol inhaler, long-acting beta-2 agonist inhaler high dose inhaled corticosteroids. Oral prednisone can also be used.”